Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Hizentra

Hizentra 200 mg/ml solution for subcutaneous injection Hizentra 200 mg/ml solution for subcutaneous injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 8

HOS-124355 · Präparat HOS-095847

System Organ ADRs (MedDRA Preferred Term, PT) ADR frequency ADR frequency Class category per patient category per (SOC, MedDRA) infusion Immune system Hypersensitivity Uncommon Rare disorders Anaphylactic reaction Unknown Unknown Nervous system Headache Very common Uncommon disorders Dizziness, Migraine Common Rare Tremor (including Psychomotor Uncommon Rare hyperactivity) Meningitis aseptic Uncommon Very rare Burning sensation Unknown Unknown Cardiac disorders Tachycardia Uncommon Very rare Vascular disorders Hypertension Common Rare Flushing Uncommon Rare Embolic and thrombotic events Unknown Unknown Gastrointestinal Diarrhoea, Abdominal pain Common Uncommon disorders Nausea, Vomiting Common Rare Skin and Rash Very common Uncommon subcutaneous Pruritus, Urticaria Common Rare tissue disorders Musculoskeletal Musculoskeletal pain, Arthralgia Common Uncommon and connective Muscle spasm, Muscular weakness Uncommon Rare tissue disorders General disorders Infusion site reaction Very common Very common and administration site conditions Fatigue (including Malaise), Pyrexia Common Uncommon

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.